Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV004815034 | SCV005071819 | pathogenic | Retinal dystrophy | 2023-01-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005089563 | SCV005834546 | uncertain significance | PRPH2-related disorder | 2024-04-30 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 219 of the PRPH2 protein (p.Pro219Arg). This variant is present in population databases (rs61755808, gnomAD 0.003%). This missense change has been observed in individual(s) with macular dystrophy or central areolar choroidal dystrophy (PMID: 9443872, 34411390). ClinVar contains an entry for this variant (Variation ID: 98696). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PRPH2 protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Retina International | RCV000085008 | SCV000117144 | not provided | not provided | no assertion provided | not provided | ||
Leiden Open Variation Database | RCV000085008 | SCV001744984 | likely pathogenic | not provided | 2021-04-06 | no assertion criteria provided | curation | Curator: Global Variome, with Curator vacancy. Submitter to LOVD: Manon Peeters. |